Harding Richard
Cicely Saunders Institute, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, Bessemer Road, London SE5 9PJ, UK.
Ecancermedicalscience. 2022 Apr 28;16:1378. doi: 10.3332/ecancer.2022.1378. eCollection 2022.
To achieve universal health coverage goals, access to quality palliative care must be rapidly scaled up in low and middle-income countries. By 2060, people living with cancer at the end of life will be the major contributors to serious health-related suffering. Major developments have occurred in the science of palliative care research in low- and middle-income countries (LMIC), from the development and validation of outcome measures to the delivery of randomised controlled trials. While the evidence has demonstrated context-specific needs among patients and families facing life-limiting illness, there are also many commonalities. Specific areas of leadership in the field have emerged from LMIC in HIV palliative care and in care for children. These innovations offer enormous potential for adaptation in high income countries. International partnerships in research, founded on mutually beneficial learning and capacity building, are central to achieving universal health coverage goals.
为实现全民健康覆盖目标，中低收入国家必须迅速扩大优质姑息治疗的可及性。到2060年，临终癌症患者将成为严重健康相关痛苦的主要来源。从中低收入国家（LMIC）姑息治疗研究科学领域的重大进展，包括结局指标的开发与验证到随机对照试验的开展，都能体现。虽然证据表明，面临生命有限疾病的患者及其家庭有特定背景下的需求，但也存在许多共性。中低收入国家在艾滋病毒姑息治疗和儿童护理领域已在该领域涌现出特定的领导领域。这些创新为高收入国家的适应提供了巨大潜力。基于互利学习和能力建设建立的国际研究伙伴关系，对于实现全民健康覆盖目标至关重要。
